Pfizer downgraded to Hold at Standpoint Research (20.14 +0.67)
Standpoint Research downgrades PFE to Hold from Buy based on valuation.
Next earnings release: May 3 before market, unconfirmed. Thomson Reuters estimate: 0.58
If you enjoy the content at iBankCoin, please follow us on Twitter